Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Neuroendocrine Responses to High-Intensity Reactive Exercises: Effects on Catecholamine and Hormonal Profiles in Elite U-19 Volleyball Players

14. november 2026 oppdatert av: Youssef Zekailiche, Mohamed Lamine Debaghine Setif 2 University

Acute Catecholamine and Glucocorticoid Responses to Reactive Speed, Agility, and Quickness Exercise in Elite U-19 Volleyball Players: A Randomized Controlled Study

The goal of this explored study intends to investigate how different types of speed, agility, and quickness (SAQ) exercises effect the body's immediate hormonal and physiological reactions in young male volleyball players. Physical exercise can alter the release of hormones and other substances involved in the body's response to physical effort and stress. However, it is still ambiguous if activities that necessitate swift reflexes to unforeseen visual stimuli provide distinct outcomes in contrast to conventional exercises that entail premeditated movements. The study will include 36 competitive male volleyball players under 19 years of age from the Algerian Amateur League. Participants will be randomly assigned to one of three groups, with 12 players in each group. The first group will conduct a 10-minute reactive training session using BlazePod, an interactive lighting system that requires participants to respond swiftly to visual inputs. The second cohort will engage in a 20-minute session with the identical approach, featuring increased workout repetitions and varied rest intervals. The third group will do 10 minutes of standard volleyball-related workouts without interactive visual indications. All participants will complete one supervised workout session. Blood samples will be collected roughly five minutes before exercise and within two minutes after exercise to assess five substances: epinephrine (adrenaline), norepinephrine (noradrenaline), dopamine, cortisol, and cortisone. These chemicals are involved in the body's responses to physical exertion and stress. Heart rate will also be recorded, and participants will report how physically challenging they found the exercises using a simple grading scale. Investigators will analyse data collected prior to and following physical activity and assess if the variations differ among the three cohorts. The study intends to better understanding of how exercise duration, physical demands, and responsiveness to visual signals may influence acute hormonal responses in young volleyball players. The results could assist researchers and sports experts in comprehending the physical requirements of reactionary exercise and inform subsequent studies on athletic training. The study is not meant to assess if these activities increase long-term sports performance. No results are currently available, and it is not yet known whether one workout strategy will create distinct hormonal reactions from another.

Studieoversikt

Status

Aktiv, ikke rekrutterende

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Faktiske)

36

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Sétif, Algerie
        • Mohamed Lamine Debaghine Setif 2 University.

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

17 år til 18 år (Barn, Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Mann

Beskrivelse

Inclusion Criteria:

  • Male volleyball players within the U-19 age category.
  • Active participation in organized competitive volleyball.
  • Sufficient physical capacity to complete the prescribed high-intensity exercise protocols.
  • Absence of musculoskeletal injury or medical conditions that could compromise safe participation.
  • Willingness to complete the experimental procedures, including pre- and post-exercise venous blood sampling.

Exclusion Criteria:

  • Current musculoskeletal injury or persistent pain affecting physical performance.
  • Diagnosed cardiovascular, metabolic, endocrine, or neurological disorders that could influence exercise tolerance or biochemical responses.
  • Use of medications or substances known to affect sympathetic nervous system activity, catecholamine secretion, or glucocorticoid regulation.
  • Inability to complete the assigned exercise protocol or blood sampling procedures.
  • Withdrawal of consent at any stage of the investigation.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Grunnvitenskap
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: High-Intensity Exercise Group

12 individuals are participating in high-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program.

12 participants will undergo a single high-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses.

Eksperimentell: Moderate-Intensity Exercise Group

12 individuals will participate in moderate-intensity physical training as part of supervised sessions. Heart rate and perceived exertion levels will be monitored, and blood samples will be collected before and after the program.

12 participants will undergo a single moderate-intensity exercise session under the supervision of specialists. The session will include a warm-up phase, followed by continuous moderate-intensity exercise, and will conclude with a cool-down phase. Exercise intensity will be monitored by measuring heart rate and assessing the perceived level of exertion. Additionally, blood samples will be collected before and after the session to evaluate hormonal responses.

Ingen inngripen: Control Group

12 participants will not undergo any physical intervention; instead, they will continue with their usual daily activities. Blood samples will be collected at the same time points established for the exercise groups.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Plasma Epinephrine Level
Tidsramme: Before and immediately after the single exercise session

Plasma epinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Plasma Norepinephrine Level
Tidsramme: Before and immediately after the single exercise session

Plasma norepinephrine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Plasma Dopamine Level
Tidsramme: Before and immediately after the single exercise session

Plasma dopamine concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Serum Cortisol Level
Tidsramme: Before and immediately after the single exercise session

Serum cortisol concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session
Change in Serum Cortisone Level
Tidsramme: Before and immediately after the single exercise session

Serum cortisone concentration measured by blood sample. Change from baseline (before exercise) to immediately after the single exercise session will be compared between the high-intensity, moderate-intensity, and control groups.

Before and immediately after the single exercise session

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Peak Heart Rate During Exercise
Tidsramme: During the exercise session

Peak heart rate (HRpeak) will be measured continuously during each exercise session using a heart rate monitor. HRpeak will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group.

During the exercise session
Rating of Perceived Exertion
Tidsramme: During and immediately after the single exercise session

The Rate of Perceived Exertion (RPE) will be assessed using the Borg scale during and immediately after each exercise session. RPE values will then be compared across the three groups: the high-intensity exercise group, the moderate-intensity exercise group, and the control group.

During and immediately after the single exercise session

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: YOUSSEF ZEKAILICHE, Ph.D., Mohamed Lamine Debaghine Setif 2 University Laboratory Sciences of Physical Activities, Sports, and Public Health, Algeria.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

5. oktober 2026

Primær fullføring (Faktiske)

15. oktober 2026

Studiet fullført (Antatt)

5. desember 2026

Datoer for studieregistrering

Først innsendt

14. november 2026

Først innsendt som oppfylte QC-kriteriene

14. november 2026

Først lagt ut (Faktiske)

19. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • SETIF2-01-2026

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared to protect participant confidentiality and privacy, as this is a small single-site. Only aggregated and anonymized results will be reported.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .